Page:ICD-10-CM (2010).djvu/2014

 also any therapeutic drug level monitoring (Z51.81)
 * Excludes2: drug abuse and dependence (F11-F19)
 * drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
 * Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets
 * Excludes2: long term (current) use of aspirin (Z79.83)
 * Z79.01 Long term (current) use of anticoagulants
 * Z79.02 Long term (current) use of antithrombotics/antiplatelets
 * Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID)
 * Excludes2: long term (current) use of aspirin (Z79.82)
 * Z79.2 Long term (current) use of antibiotics
 * Z79.3 Long term (current) use of hormonal contraceptives
 * Long term (current) use of birth control pill or patch
 * Z79.4 Long term (current) use of insulin
 * Z79.5 Long term (current) use of steroids
 * Z79.51 Long term (current) use of inhaled steroids
 * Z79.52 Long term (current) use of systemic steroids
 * Z79.8 Other long term (current) drug therapy
 * Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
 * Code first, if applicable:
 * malignant neoplasm of breast (C50.-)
 * malignant neoplasm of prostate (C61)
 * Use additional code, if applicable, to identify:
 * estrogen receptor positive status (Z17.0)
 * family history of breast cancer (Z80.3)
 * genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
 * personal history of breast cancer (Z85.3)
 * personal history of prostate cancer (Z85.46)
 * postmenopausal status (Z78.0)
 * Excludes1: hormone replacement therapy (postmenopausal) (Z79.890)
 * Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
 * Long term (current) use of raloxifene (Evista)
 * Long term (current) use of tamoxifen (Nolvadex)
 * Long term (current) use of toremifene (Fareston)
 * Z79.811 Long term (current) use of aromatase inhibitors
 * Long